Zurich Cantonal Bank
ROIV icon

Zurich Cantonal Bank’s Roivant Sciences ROIV Stock Holding History

Zurich Cantonal Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Buy
197,122
+37,106
+23% +$1.1M 0.01% 593
2026
Q1 		$4.43M Buy
160,016
+28,156
+21% +$723K 0.01% 693
2025
Q4 		$2.86M Buy
131,860
+17,810
+16% +$351K 0.01% 810
2025
Q3 		$1.73M Sell
114,050
-290
-0.3% -$3.59K ﹤0.01% 996
2025
Q2 		$1.29M Buy
114,340
+11,862
+12% +$129K ﹤0.01% 1100
2025
Q1 		$1.03M Buy
102,478
+9,357
+10% +$101K ﹤0.01% 1143
2024
Q4 		$1.1M Buy
93,121
+13,834
+17% +$164K ﹤0.01% 1137
2024
Q3 		$915K Hold
79,287
– – ﹤0.01% 1173
2024
Q2 		$838K Buy
79,287
+17,248
+28% +$189K ﹤0.01% 1164
2024
Q1 		$654K Sell
62,039
-1,697
-3% -$18.3K ﹤0.01% 1303
2023
Q4 		$716K Sell
63,736
-4,283
-6% -$41.7K ﹤0.01% 1258
2023
Q3 		$794K Buy
68,019
+5,465
+9% +$61.8K ﹤0.01% 1107
2023
Q2 		$631K Buy
62,554
+17,914
+40% +$160K ﹤0.01% 1219
2023
Q1 		$329K Buy
44,640
+4,010
+10% +$33K ﹤0.01% 1555
2022
Q4 		$325K Buy
40,630
+8,328
+26% +$46.3K ﹤0.01% 1515
2022
Q3 		$104K Hold
32,302
– – ﹤0.01% 2193
2022
Q2 		$131K Buy
+32,302
New +$128K ﹤0.01% 2051

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Zurich Cantonal Bank's ROIV Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Roivant Sciences (ROIV) stake by 23% in Q2 2026, buying an estimated $1.1M and bringing the position to 197,122 shares worth $6.98M. The position accounts for 0.01% of the portfolio, ranked #593.

Zurich Cantonal Bank first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Zurich Cantonal Bank held 197,122 shares of Roivant Sciences worth $6.98M as of Q2 2026.
  • Zurich Cantonal Bank bought 37,106 Roivant Sciences shares in Q2 2026, an estimated $1.1M.
  • Roivant Sciences made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #593 holding.
  • Zurich Cantonal Bank first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.